SYDNEY, Feb 4 (Bernama-GLOBE NEWSWIRE) — George Clinical announces that the organization has been accredited by the Australian Office of the Gene Technology Regulator (OGTR) which allows it to be a licence holder for studies involving the use of genetically modified organisms (GMOs).
The addition of this capability means that George Clinical can now, under the Gene Technology Act 2000 and Gene Technology Regulations 2001, undertake DIR (dealings involving intentional release) and DNIR (dealings not involving intentional release) licensing and execute studies inclusive of the required writing of DIR and DNIR applications as well as IBC (Institutional Biosafety Committee) review. Being OGTR accredited enables George Clinical to hold a license in the name of a sponsoring company.
- More than 83 mn people internally displaced worldwide: monitor
- Syria Welcomes U.S. President’s Remarks On Potential Sanctions Relief
- Egypt’s Central Bank Reports Record 72.4-Percent Surge In Expatriates’ Remittances Over 12 Months
- US Pres Trump heads for Saudi Arabia on major Middle East tour
- Hamas Released Israeli-U.S. Hostage Yesterday
- Australian PM Albanese, Ministers Sworn In Following Election Victory
- Moderate Candidate Ley Wins Leadership Of Australia’s Conservative Opposition Party
- Philippine Ex-President Duterte Wins Mayoral Race In Mid-Term Elections: Preliminary Results
- Türkiye’s PKK Announced Dissolution, Ends Armed Struggle
- S. Korea Kicked Off Official Campaign For June 3 Presidential Election